about
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalaprilInteractions among vascular-tone modulators contribute to high altitude pulmonary edema and augmented vasoreactivity in highlandersACE inhibition and atherogenesis.Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state.AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats.Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials.The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease.Exercise protects against chronic β-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthase.Stressing the system.Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway.High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats.Endothelial cell dysfunction: can't live with it, how to live without it.Targeting calcineurin and associated pathways in cardiac hypertrophy and failure.Vascular responses to long- and short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution)Distribution of the activity of the angiotensin-converting enzyme in the rat aorta and changes in the activity with aging and by the action of L-NAME.Modulation of Vascular ACE by Oxidative Stress in Young Syrian Cardiomyopathic Hamsters: Therapeutic ImplicationsThe renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesEffects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone.Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes.Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.Update on adipose tissue blood flow regulation.Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism.Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins.Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord.Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril.17Beta-oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats.Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms.Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
P2860
Q28269008-E74C1019-0216-474D-BC13-74F07966B842Q28483668-DE099016-94D3-476E-A59E-48770751E8E8Q34652136-3F4D8DA1-E0CE-4766-B30D-67BF2E0C55EEQ35034973-2FF946C7-A7C0-4AA3-ACD4-AFDC6D8E25D1Q35089883-4A7C6F43-F3E9-4F14-8ABA-642EDD1299A9Q35111064-B806566D-6D45-4AF2-BB9A-84BDFBEC0961Q35117065-2BFED1B3-4F6A-4B3B-997D-A30C88053588Q35165245-CA289EBB-AE32-45F1-9736-0583F1124B07Q35178628-A392C6D8-05C7-4422-8B25-7AB0599DC214Q35206668-F12FFCA4-67F7-412C-B04A-E67BFB5FD142Q35214333-2E5F1A5F-A0E4-447E-ADDF-19FA02436046Q36093993-671A1326-66FD-4940-9073-7DE41CDFEE46Q36268310-5E05326D-31AB-4FF1-A638-91FEB08A0867Q36879472-0AA3E50B-E682-401E-A863-46BD088FECAFQ36927443-A9E8E69F-C351-4668-AA08-48E9ABB71149Q37128348-6AF48D75-7805-4B45-B1D2-BF1087B184F4Q37158159-426F4194-D368-40BE-A6A8-E1FCA024C9B7Q37300636-AFA70B97-ACFE-463E-8954-957A072FDA6FQ37312565-804F44FC-D8E5-45E4-AD46-DD35CF24F387Q37430950-A23CDCD6-7B37-46D9-AC37-C3E96F7FB0DFQ37982682-4873576D-BFBD-44F4-ABB9-22BDE1E69E03Q42224915-5C4FB550-227E-498B-9819-EB69DB719F03Q43811771-FF9507F0-8E07-410D-AC3D-28B02717B1D5Q44315267-61EDA4E9-97E8-4681-B43E-B379F84D1948Q44649425-E72B7380-8D74-4B46-9AB4-6D876F2F6107Q51437723-60FFB8F9-182C-4A73-8D5E-D6FAD50BFDF3Q51809464-C5F5E3DA-709A-4FCD-8E7F-A65A630E479CQ54567730-458A6FD1-EDD4-47CE-9AEE-01781018ABEAQ54581677-5A8B6E71-585B-4DD8-9535-54D6E5983FBF
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Interactions among ACE, kinins and NO.
@ast
Interactions among ACE, kinins and NO.
@en
type
label
Interactions among ACE, kinins and NO.
@ast
Interactions among ACE, kinins and NO.
@en
prefLabel
Interactions among ACE, kinins and NO.
@ast
Interactions among ACE, kinins and NO.
@en
P2093
P1476
Interactions among ACE, kinins and NO.
@en
P2093
P304
P356
10.1016/S0008-6363(99)00091-7
P577
1999-08-01T00:00:00Z